Top Quality Peptides Tirzepatide

Tirzepatide  is a dual glucose-dependent insulinotropic polypeptide  and glucagon-like peptide-1  receptor agonist that is being developed for the treatment of type 2 diabetes. Tirzepatide  shows significantly better efficacy with regard to glucose control and weight loss than do Dulaglutide. Tirzepatide, also known as LY 3298176, is a dual glucose-dependent insulinotropic polypeptide  and glucagon-like peptide-1  receptor agonist. Tirzepatide has a greater affinity to GIP receptors than to GLP-1 receptors, and this dual agonist behavior has been shown to produce greater reductions of hyperglycemia compared to a selective GLP-1 receptor agonist. Signaling studies reported that tirzepatide mimics the actions of natural GIP at the GIP receptor. Tirzepatide was approved for improving blood sugar control in adults with type 2 diabetes, as an addition to diet and exercise.